SuperworthRevelation Biosciences shares outstanding REVB
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 547.1K
- On a year earlier
- +1808.3%
- more shares
Revelation Biosciences had 547.1K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1808.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 4.1K | +2017% |
| FY2023 | 195 | +185% |
| FY2022 | 68 | +1018% |
| FY2020 | 6 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 547.1K | +1808% | |
| Q1 FY26 | 458.2K | +3863% | |
| Q3 FY25 | 94.5K | +4637% | |
| Q2 FY25 | 28.7K | +2256% | |
| Q1 FY25 | 11.6K | +1326% | |
| Q4 FY24 | 4.1K | +2017% | |
| Q3 FY24 | 2K | +913% | |
| Q2 FY24 | 1.2K | +558% | |
| Q1 FY24 | 811 | +556% | |
| Q4 FY23 | 195 | +185% | |
| Q3 FY23 | 197 | +1197% | |
| Q2 FY23 | 185 | +1588% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Revelation Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.